Mesquite volunteers make dream come for cancer patient
Found on 05 Jun 2008 07:06 GMT
Heroes for Children, an organization that helps families with children diagnosed with cancer, and John Q. Hammons Hotels and Resorts created a young woman?s dream celebration Saturday night.
New Drug Application Filing for Levoleucovorin Tablets Completed by Spectrum Pharmaceuticals, Inc.
Found on 05 Jun 2008 11:00 GMT
IRVINE, Calif.-Spectrum Pharmaceuticals, Inc. today announced that it has completed its filing with the U.S. Food and Drug Administration with the filing of an amendment to the New Drug Application for Levoleucovorin Tablets.
May 28, 2008 Edition
Found on 03 Jun 2008 17:50 GMT
Log in above for full coverage, or subscribe now!
Senior spent most of year at home
Found on 01 Jun 2008 08:07 GMT
Hickory - Hickory High School senior Steven Dulin has spent the majority of the school year at home. Diagnosed in June 2007 with osteosarcoma, the teen has missed out on much of the usual senior-year activities. I got hurt playing basketball, and I never got better. I went to the doctor, and on June 1 (2007), I was diagnosed, Dulin said. The cancer was primarily in his right hip on his femur, ...
Nashua teen sets sights on eradicating cancer
Found on 02 Jun 2008 16:30 GMT
NASHUA - Ask Justin Stanton what his ambition is. As an aspiring entrepreneur, he won't hesitate to tell you it's to make as much money as possible. The 19-year-old Nashua resident, who grew up watching his father battle both bone and brain cancer, knows more research money might have saved hid dad's leg from amputation - and his life.
Lifewatch: Bone Cancer
Found on 02 Jun 2008 18:11 GMT
Nearly 2,400 people will face bone cancer this year, but a new surgery is saving people from the traditional amputation treatment.
2008-06-02 14:40 IDM Pharma shares up in premarket on Phase II follow-up data for IDM-2101
Found on 02 Jun 2008 14:08 GMT
BOSTON (Thomson Financial) - Shares of IDM Pharma Inc. rallied in premarket trades Monday after the Irvine, Calif.-based biopharmaceutical company reported positive results for its IDM-2101 Phase II study.
IDM Pharma Announces Data Supporting Improved Overall Survival Advantage in Newly Diagnosed Patients with Metastatic ...
Found on 02 Jun 2008 11:30 GMT
IDM Pharma, Inc. today announced the presentation of an analysis from the Phase 3 mifamurtide clinical trial .
Firefighter renews battle against cancer: Experimental treatment is up next in third bout with disease
Found on 01 Jun 2008 12:25 GMT
There's more to Robby Cowart than his disease. He's a firefighter. He's a family man. He's a beloved friend. He also refuses to let his battle with cancer keep him down.
Pavlik is Youngstown's man of steel (The News-Herald)
Found on 01 Jun 2008 07:01 GMT
First in a three-part series. Part 2 on Monday: Pavlik's early years in boxing. Part 3 on Tuesday: Pavlik's unique training methods YOUNGSTOWN - The gym that raised this world champion is old and tired, just like his city. In a former life, it was a mom-and-pop pizza shop, and it shows.
Protease expression in dedifferentiated parosteal osteosarcoma
* Background-Parosteal osteosarcoma with dedifferentiation provides a useful model to study tumor progression from an indolent locally aggressive neoplasm to highly lethal metastasizing malignancy. Up-regulation of the proteolytic enzymes participating in stromal degradation is known to promote
Osteosarcoma: A Multidisciplinary Approach to Diagnosis and Treatment.
The treatment of osteosarcoma requires a multidisciplinary approach involving the family physician, orthopedic oncologist, medical oncologist, radiologist and pathologist. Osteosarcoma is a mesenchymally derived, high-grade bone sarcoma. It is the third most common malignancy in children and
Osteosarcoma.
What is osteosarcoma? Osteosarcoma is a kind of bone cancer. It most often starts in a leg bone (either the femur or the tibia) in the area of the knee or in the upper arm bone (the humerus) near the shoulder. Osteosarcoma can spread (metastasize) to other parts of the body, most often to the lungs
Osteosarcoma metastasising to the duodenum and pancreas
The incidence of metastatic osteosarcoma is increasing because of improved results following multi-agent chemotherapy and resection of the primary tumour. Metastases occur most commonly in the lungs, whereas bowel metastases are rare. We describe a 25-year-old female who presented with melaena six
High-Grade Pelvic Osteosarcoma With Intravascular Extension to the Right Side of the Heart: A Case Report and Review of the Literature
* We describe a rare case of high-grade osteosarcoma with intravascular extension to the right atrium and right ventricle in a 23-year-old woman. Osteosarcomas rarely metastasize to the heart, and only a few cases have been reported in the literature thus far. Diagnoses in some of these cases were
Osteosarcoma around the knee: INTRAEPIPHYSEAL EXCISION AND BIOLOGICAL RECONSTRUCTION WITH DISTRACTION OSTEOGENESIS
In 11 patients juxta-articular osteosarcoma around the knee was treated by intraepiphyseal excision of the tumour and reconstruction of the bone defect by distraction osteogenesis. Preoperative and postoperative chemotherapy was given to eight patients with high-grade tumours. The articular
Calcified left ventricular mass: Unusual clinical, echocardiographic, and computed tomographic findings of primary cardiac osteosarcoma
Primary cardiac osteosarcomas are rare and usually originate in the left atrium. In contrast, osteosarcomas metastatic to the heart most commonly involve the right cardiac chambers. This case report describes an unusual primary cardiac osteosarcoma, initially observed as a slowly growing, densely
Fatal pulmonary tumor embolism caused by chondroblastic osteosarcoma: Report of a case and review of the literature
Fatal pulmonary tumor embolism is an unusual phenomenon that has only rarely been reported with osteosarcoma. It usually presents with typical symptoms and signs of pulmonary thromboembolism. The authors report the case of a 65-year-old woman with chondroblastic osteosarcoma of the distal femur who
IDM PHARMA SUBMITS NDA FOR JUNOVAN OSTEOSARCOMA TREATMENT.
IDM Pharma (NASDAQ:IDMI), Irvine, Calif., has submitted an electronic New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Junovan (mifamurtide for injection), requesting approval for its use in the treatment of newly diagnosed resectable high grade osteosarcoma patients
^sup 99m^Tc-MIBI Imaging as a Predictor of Therapy Response in Osteosarcoma Compared with Multidrug Resistance-Associated Protein and P-Glycoprotein Expression
In vitro studies have demonstrated that ^sup 99m^Tc-methoxyisobutylisonitriie (^sup 99m^Tc-MIBI) is a transport substrate of multidrug resistance (MDR)-related proteins. The aim of this clinical study was to evaluate whether ^sup 99m^Tc-MIBI scintigraphy was a functional imaging tool for in vivo
